GE HealthCare Technologies (NASDAQ:GEHC) Releases FY 2026 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) issued an update on its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 4.800-5.000 for the period, compared to the consensus estimate of 4.870. The company issued revenue guidance of -. GE HealthCare Technologies also updated its Q2 2026 guidance to EPS.

GE HealthCare Technologies Stock Down 2.3%

NASDAQ:GEHC traded down $1.45 during trading hours on Friday, hitting $60.54. 762,988 shares of the company traded hands, compared to its average volume of 4,414,466. GE HealthCare Technologies has a one year low of $58.75 and a one year high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a market cap of $27.54 billion, a PE ratio of 14.45, a PEG ratio of 1.67 and a beta of 0.72. The firm’s 50-day simple moving average is $63.64 and its 200-day simple moving average is $71.31.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts predict that GE HealthCare Technologies will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on GEHC shares. Zacks Research cut shares of GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a report on Tuesday. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Jefferies Financial Group reduced their price target on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Finally, Hovde Group began coverage on GE HealthCare Technologies in a research report on Friday, July 17th. They set a “market perform” rating and a $14.00 price target on the stock. Ten analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $76.41.

Insider Activity

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,750 shares of the business’s stock in a transaction dated Thursday, April 30th. The shares were acquired at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the acquisition, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This trade represents a 3.93% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders purchased 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare said its preliminary Q2 2026 results and reaffirmed FY 2026 guidance reflect continued business momentum, signaling that core operations remain on track. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
• Positive Sentiment: The company’s FY 2026 EPS guidance of $4.80 to $5.00 was reiterated, suggesting management still expects stable earnings performance despite leadership changes. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
• Neutral Sentiment: The company announced that CFO Jay Saccaro will step down, which creates near-term uncertainty but does not appear tied to an operational breakdown. GE HealthCare CFO to step down
• Neutral Sentiment: A securities-fraud investigation and related shareholder-lawyer outreach could keep investor sentiment cautious, but these are allegations rather than confirmed wrongdoing. GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
• Neutral Sentiment: Another law firm also expanded its securities-fraud probe, adding legal overhang but no new operational details. Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
• Negative Sentiment: Zacks Research downgraded GE HealthCare from Hold to Strong Sell, which likely added to the selling pressure. Zacks Research downgrade

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of GEHC. Transamerica Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 262 shares during the last quarter. Zions Bancorporation National Association UT raised its position in shares of GE HealthCare Technologies by 125.1% in the fourth quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock valued at $34,000 after purchasing an additional 229 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in GE HealthCare Technologies during the 4th quarter worth $34,000. Miller Capital Partners Inc. bought a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $38,000. Finally, Palisade Asset Management LLC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $41,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.